Harri M N
Med Biol. 1977 Oct;55(5):268-76.
Rats were treated by daily alprenolol (10, 20 and 50 mg/kg) injections for 5 days a week for 4 weeks. At 20--21 degrees C alprenolol treatment retarded the weight gain of the animals and increased the weight of the adrenals. These changes were not seen at 29 degrees C. The reduction in size and fat content of the interscapular brovin adipose tissue in drug-treated rats was independent of experimental temperature. At 20--21 degrees C prolonged beta-blockade did not cause any changes in the enzymes of the energy metabolism. At 29 degrees C, however, alprenolol treatment antagonized the decrease in activity of oxidative enzymes (succinate dehydrogenase, malate dehydrogenase, citrate synthase) and the decrease in protein concentration of the cardiac muscle. In skeletal muscle alprenolol treatment significantly decreased the activities of oxidative enzymes and antagonized the rise in the activity of lactate dehydrogenase resulting from warm acclimation. The increased activities of oxidative enzymes in interscapular brown adipose tissue of aprenolol treated rats were coupled with an increase in protein concentration of the tissue. Although these changes were more marked at 29 degree C they were observable at 20--21 degree C, too. The difference in the drug effects at 20--21 degrees C and 29 degrees C can be accounted for by the compensatory catecholamine release at the lower temperature, due to impaired thermoregulatory capacity after alprenolol. Prolonged beta blockade decreased the exercise tolerance and cold tolerance of the rats. An increased response of the diastolic blood pressure to an alpha-adrenergic drug, noradrenaline, and a decreased response to a beta-adrenergic drug, isoprenaline, in alprenolol-treated rats indicates a shift from beta- to alpha-receptors.
大鼠每周 5 天,连续 4 周每天注射阿普洛尔(10、20 和 50 毫克/千克)。在 20 - 21 摄氏度时,阿普洛尔治疗会延缓动物体重增加并增加肾上腺重量。在 29 摄氏度时未观察到这些变化。药物治疗的大鼠肩胛间棕色脂肪组织大小和脂肪含量的减少与实验温度无关。在 20 - 21 摄氏度时,长期的β受体阻断未引起能量代谢酶的任何变化。然而,在 29 摄氏度时,阿普洛尔治疗拮抗了氧化酶(琥珀酸脱氢酶、苹果酸脱氢酶、柠檬酸合酶)活性的降低以及心肌蛋白质浓度的降低。在骨骼肌中,阿普洛尔治疗显著降低了氧化酶的活性,并拮抗了因温热适应导致的乳酸脱氢酶活性的升高。阿普洛尔治疗的大鼠肩胛间棕色脂肪组织中氧化酶活性的增加与该组织蛋白质浓度的增加相关。尽管这些变化在 29 摄氏度时更明显,但在 20 - 21 摄氏度时也可观察到。20 - 21 摄氏度和 29 摄氏度时药物作用的差异可归因于较低温度下由于阿普洛尔后体温调节能力受损导致的代偿性儿茶酚胺释放。长期的β受体阻断降低了大鼠的运动耐力和耐寒性。阿普洛尔治疗的大鼠舒张血压对α肾上腺素能药物去甲肾上腺素的反应增加,而对β肾上腺素能药物异丙肾上腺素的反应降低,表明从β受体向α受体的转变。